Category: Top Story
-
EchoStar shares jump as Verizon reportedly eyes wireless spectrum acquisition
EchoStar (NASDAQ:SATS) saw its shares rise more than 6% in premarket trading Tuesday after reports suggested that Verizon Communications (NYSE:VZ) is exploring the purchase of the company’s wireless spectrum. Bloomberg reported Monday that Verizon is in talks to acquire EchoStar’s AWS-3 licenses, which support 5G network operations. If finalized, the transaction would place Verizon alongside…
-
Dollar Weakens Ahead of U.S. Government Shutdown and Key Labor Data
The U.S. dollar edged lower on Tuesday as investors weighed the risk of a looming government shutdown and the release of important employment statistics. By 05:25 ET (09:25 GMT), the Dollar Index, which tracks the greenback against six major currencies, fell 0.2% to 97.442. Shutdown Risks Heighten Market Uncertainty With lawmakers racing against the clock…
-
S&P 500: Why the Market Bubble May Not Burst Just Yet
Talk of a bubble in the U.S. stock market has intensified as the S&P 500 approaches record levels, yet some analysts suggest there’s still upside potential. John Higgins, chief markets economist at Capital Economics, sees room for the index to surpass his current 6,750 forecast for the end of 2025 and possibly extend gains into…
-
Boeing Explores Plans for 737 MAX Replacement, WSJ Says
Boeing Co (NYSE:BA) is reportedly planning a new single-aisle aircraft to eventually replace the 737 MAX, aiming to recover market share lost to Airbus (EU:AIR), according to the Wall Street Journal on Monday, citing sources familiar with the matter. The report states that CEO Kelly Ortberg met earlier this year with Rolls-Royce Holdings PLC (LSE:RR.)…
-
Oil Slips on OPEC+ Supply Hike and Kurdish Export Resumption
Crude oil prices declined on Tuesday as investors weighed an anticipated increase in OPEC+ production alongside the resumption of oil exports from Iraq’s semi-autonomous Kurdistan region via Turkey, stoking concerns about a potential oversupply. November Brent crude futures, expiring on Tuesday, fell 28 cents, or 0.4%, to $67.69 a barrel by 06:30 GMT, while December…
-
Gold Climbs to Record Levels as U.S. Shutdown Risk Weighs on Markets
Gold prices surged to new record highs in Asian trading on Tuesday, extending a strong rally over the past week as investors weighed the risk of an impending U.S. government shutdown. Persistent expectations for additional Federal Reserve rate cuts also supported metals, although silver and platinum eased slightly after Monday’s sharp gains. Copper prices also…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Futures Slide as Shutdown Deadline Looms; Gold Surges
U.S. equity futures moved lower on Tuesday as investors focused on a tense standoff in Washington over federal funding, with a potential government shutdown just hours away. A meeting between Republican and Democratic leaders and President Donald Trump on Monday ended without resolution, amplifying uncertainty. The risk of a shutdown has helped push gold prices…
-
Electronic Arts Set to Go Private in $55 Billion Deal Led by Saudi PIF and Silver Lake
Electronic Arts (NASDAQ:EA), the renowned video game developer behind franchises such as Battlefield and Madden NFL, is set to go private in a $55 billion transaction backed by Saudi Arabia’s Public Investment Fund (PIF), Silver Lake, and Jared Kushner’s Affinity Partners. Under the agreement, EA shareholders will receive $210 per share in cash, with PIF…
-
Carnival Shares Surge Following Record-Breaking Q3 Earnings
Carnival Corporation (NYSE:CCL) shares climbed 5% in premarket trading Monday after the cruise giant reported record third-quarter results that exceeded Wall Street expectations, driven by robust demand and higher onboard pricing. The company posted adjusted earnings of $1.43 per share for Q3, surpassing analyst forecasts of $1.32. Revenue reached a new high of $8.2 billion,…
-
Applied Therapeutics Shares Plunge Following FDA Meeting on CMT-SORD Treatment
Applied Therapeutics (NASDAQ:APLT) saw its stock dive 55% in premarket trading Monday after the company disclosed uncertainty around the regulatory pathway for govorestat, its therapy for Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD). The clinical-stage biopharmaceutical firm recently met with the U.S. Food and Drug Administration (FDA) to discuss a potential new drug application for govorestat. However,…